Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster rando...
Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Screening men for prostate cancer using prostate-specific antigen (PSA) testing remains controversial. We aimed to estimate the likely budgetary impact on secondary care in England and Wales to inform screening decision makers.
The Cluster randomised triAl of PSA testing for Prostate cancer study (CAP) compared a single invitation to men aged 50...
Alternative Titles
Full title
Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a4968535cc4746dabf844d0f842edc58
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4968535cc4746dabf844d0f842edc58
Other Identifiers
ISSN
1472-6963
E-ISSN
1472-6963
DOI
10.1186/s12913-023-09503-7
